Anti-CD20 treatment of relapsed or refractory Immune Thrombocytopenic Purpura (ITP) after first line corticosteroid treatment.
Completed
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1. Age minimal 18 years;
Exclusion Criteria
1. The presence of an accessory spleen in splenectomized patients;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The response (CR/GR/MR/NR) to treatment.<br>
- Secondary Outcome Measures
Name Time Method 1. Need for emergency treatment (platelet count <10 or hemorrhagic diathesis, hemorrhage/bleeding defined by grade 3 or 4 according to NCI CTCAE v3.0);<br><br />2. Time to treatment failure/relapse.